🚀 VC round data is live in beta, check it out!
LifeStance Health Valuation Multiples
Discover revenue and EBITDA valuation multiples for LifeStance Health and similar public comparables like IKS Health, Topchoice Medical, Acadia Healthcare, Guardian Pharmacy Service and more.
LifeStance Health Overview
About LifeStance Health
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The group y has a single operating and reportable segment of mental health services.
Founded
2021
HQ
Employees
10.2K
Website
Sectors
Financials (LTM)
EV
$3B
LifeStance Health Financials
LifeStance Health reported last 12-month revenue of $1B and EBITDA of $168M.
In the same LTM period, LifeStance Health generated $485M in gross profit, $168M in EBITDA, and $17M in net income.
Revenue (LTM)
LifeStance Health P&L
In the most recent fiscal year, LifeStance Health reported revenue of $1B and EBITDA of $158M.
LifeStance Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Profit | $485M | XXX | $461M | XXX | XXX | XXX |
| Gross Margin | 33% | XXX | 32% | XXX | XXX | XXX |
| EBITDA | $168M | XXX | $158M | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 11% | XXX | XXX | XXX |
| EBIT Margin | 2% | XXX | 2% | XXX | XXX | XXX |
| Net Profit | $17M | XXX | $10M | XXX | XXX | XXX |
| Net Margin | 1% | XXX | 1% | XXX | XXX | XXX |
| Net Debt | — | — | $32M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
LifeStance Health Stock Performance
LifeStance Health has current market cap of $3B, and enterprise value of $3B.
Market Cap Evolution
LifeStance Health's stock price is $6.89.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $3B | 3.3% | XXX | XXX | XXX | $0.03 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLifeStance Health Valuation Multiples
LifeStance Health trades at 1.9x EV/Revenue multiple, and 17.0x EV/EBITDA.
EV / Revenue (LTM)
LifeStance Health Financial Valuation Multiples
As of April 18, 2026, LifeStance Health has market cap of $3B and EV of $3B.
Equity research analysts estimate LifeStance Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
LifeStance Health has a P/E ratio of 155.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV/Revenue | 1.9x | XXX | 2.0x | XXX | XXX | XXX |
| EV/EBITDA | 17.0x | XXX | 18.2x | XXX | XXX | XXX |
| EV/EBIT | 86.7x | XXX | 118.6x | XXX | XXX | XXX |
| EV/Gross Profit | 5.9x | XXX | 6.2x | XXX | XXX | XXX |
| P/E | 155.8x | XXX | 272.9x | XXX | XXX | XXX |
| EV/FCF | 25.5x | XXX | 26.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified LifeStance Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
LifeStance Health Margins & Growth Rates
LifeStance Health's revenue in the last 12 month grew by 15%.
LifeStance Health's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
LifeStance Health's rule of 40 is 27% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
LifeStance Health's rule of X is 49% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
LifeStance Health Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 15% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Growth | 23% | XXX | 23% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 27% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 49% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| G&A Expenses to Revenue | 25% | XXX | 27% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 31% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
LifeStance Health Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| LifeStance Health | XXX | XXX | XXX | XXX | XXX | XXX |
| IKS Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Topchoice Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Acadia Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Guardian Pharmacy Service | XXX | XXX | XXX | XXX | XXX | XXX |
| Krishna Institute | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
LifeStance Health M&A Activity
LifeStance Health acquired XXX companies to date.
Last acquisition by LifeStance Health was on XXXXXXXX, XXXXX. LifeStance Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by LifeStance Health
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialLifeStance Health Investment Activity
LifeStance Health invested in XXX companies to date.
LifeStance Health made its latest investment on XXXXXXXX, XXXXX. LifeStance Health invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by LifeStance Health
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout LifeStance Health
| When was LifeStance Health founded? | LifeStance Health was founded in 2021. |
| Where is LifeStance Health headquartered? | LifeStance Health is headquartered in United States. |
| How many employees does LifeStance Health have? | As of today, LifeStance Health has over 10K employees. |
| Who is the CEO of LifeStance Health? | LifeStance Health's CEO is David P. Bourdon. |
| Is LifeStance Health publicly listed? | Yes, LifeStance Health is a public company listed on Nasdaq. |
| What is the stock symbol of LifeStance Health? | LifeStance Health trades under LFST ticker. |
| When did LifeStance Health go public? | LifeStance Health went public in 2021. |
| Who are competitors of LifeStance Health? | LifeStance Health main competitors are IKS Health, Topchoice Medical, Acadia Healthcare, Guardian Pharmacy Service. |
| What is the current market cap of LifeStance Health? | LifeStance Health's current market cap is $3B. |
| What is the current revenue of LifeStance Health? | LifeStance Health's last 12 months revenue is $1B. |
| What is the current revenue growth of LifeStance Health? | LifeStance Health revenue growth (NTM/LTM) is 15%. |
| What is the current EV/Revenue multiple of LifeStance Health? | Current revenue multiple of LifeStance Health is 1.9x. |
| Is LifeStance Health profitable? | Yes, LifeStance Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of LifeStance Health? | LifeStance Health's last 12 months EBITDA is $168M. |
| What is LifeStance Health's EBITDA margin? | LifeStance Health's last 12 months EBITDA margin is 11%. |
| What is the current EV/EBITDA multiple of LifeStance Health? | Current EBITDA multiple of LifeStance Health is 17.0x. |
| What is the current FCF of LifeStance Health? | LifeStance Health's last 12 months FCF is $112M. |
| What is LifeStance Health's FCF margin? | LifeStance Health's last 12 months FCF margin is 8%. |
| What is the current EV/FCF multiple of LifeStance Health? | Current FCF multiple of LifeStance Health is 25.5x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.